SanBio Co Stock

SanBio Co Net Debt per Share

The Net Debt per Share of SanBio Co (4592.T) as of Aug 13, 2026 is -36.66 JPY. In the previous year, Net Debt per Share was -55.03 JPY — a change of -33.39% (higher).

Net Debt per Share

-36.66JPY

YoY

-33.39%

Last updated:

Net Debt per Share of SanBio Co is 2026 -36.66 JPY. Net Debt per Share of SanBio Co was 2025 -55.03 JPY. It decreases by -33.39% higher compared to the previous year.
Access this data via the Eulerpool API

SanBio Co Stock analysis

What does SanBio Co do? SanBio Co Ltd is a leading bio-pharmaceutical company focused on the development of products for the treatment of serious neurological diseases. The company was founded in Japan in 2000 and has since become a multinational company with offices in the USA and Europe. Answer: SanBio Co Ltd is a bio-pharmaceutical company that specializes in developing products for the treatment of serious neurological diseases. It was founded in Japan in 2000 and has expanded to become a multinational company with offices in the USA and Europe. SanBio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SanBio Co stock

Net Debt per Share of SanBio Co is -36.66 JPY in 2026.

Net Debt per Share of SanBio Co changed from -55.03 JPY to -36.66 JPY, representing a -33.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share SanBio Co since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

Other — SanBio Co

All Key Metrics — SanBio Co